Abstract
Purpose
The aims of this study were to determine the proportion of return to work (RTW) among sick-listed patients diagnosed with one of eight subtypes of hematological malignancies; to evaluate the influence of type of hematological malignancy, comorbidity, use of anxiolytics and antidepressants, socioeconomic and demographic factors on RTW; and to investigate if these associations differ between genders.
Methods
We combined data from national registers on all Danish patients diagnosed with hematological malignancies between 2000 and 2007. A total of 1,741 patients on long-term sick leave were followed until RTW, emigration, permanent withdrawal from the labor market, death, or February 2012, whichever came first.
Results
A total of 1,140 (65 %) patients returned to work. A strong association was found between type of diagnosis and RTW (p < 0.001), and the proportion of RTW was lowest for patients with multiple myeloma or acute leukemia compared to patients with Hodgkin lymphoma, diffuse large B-cell lymphoma, follicular lymphoma, chronic myeloid leukemia, and chronic lymphoid leukemia. Use of antidepressants or anxiolytics after diagnosis, gender, age, and educational level were also associated with RTW. Surprisingly, comorbidity was not associated with RTW (p = 0.94); gender only modified the association between age and RTW.
Conclusion
Two thirds of patients with hematological malignancies on sick leave RTW. A number of factors seem to lead to a poor prognosis, the hematological diagnosis being the most important, and these should be taken into account when performing studies on work outcome for patients with hematological malignancies.
Implications for Cancer Survivors
Knowledge in this area should assist in identification of hematological cancer patients at risk of not returning to work so that early targeted rehabilitation interventions can be initiated.
Similar content being viewed by others
References
Pakkeforløb for hæmatologiske kræftformer, København: Sundhedsstyrelsen, 2009.
Engholm G, Ferlay J, Christensen N, Johannesen TB, Klint Å, Køtlum JE, Milter MC, Ólafsdóttir E, Pukkala E, Storm HH. NORDCAN: cancer incidence, mortality, prevalence and survival in the Nordic countries, version 5.2, Association of the Nordic Cancer Registries. Danish Cancer Society. http://www.ancr.nu.
McGrath PD, Hartigan B, Holewa H, Skarparis M. Returning to work after treatment for haematological cancer: findings from Australia. Support Care Cancer. 2012;20:1957–64.
Torp S, Nielsen RA, Gudbergsson SB, Fossa SD, Dahl AA. Sick leave patterns among 5-year cancer survivors: a registry-based retrospective cohort study. J Cancer Surviv. 2012;6:315–23.
Syse A, Tretli S, Kravdal O. Cancer’s impact on employment and earnings—a population-based study from Norway. J Cancer Surviv. 2008;2:149–58.
Carlsen K, Oksbjerg Dalton S, Frederiksen K, Diderichsen F, Diderichsen C. Cancer and the risk for taking early retirement pension: a Danish cohort study. Scand J Public Health. 2008;36:117–25.
Short PF, Vasey JJ, Tunceli K. Employment pathways in a large cohort of adult cancer survivors. Cancer. 2005;103:1292–301.
Roelen CA, Koopmans PC, Groothoff JW, van der Klink JJ, Bultmann U. Sickness absence and full return to work after cancer: 2-year follow-up of register data for different cancer sites. Psychooncology. 2011;20(9):1001–6.
Park JH, Park EC, Park JH, Kim SG, Lee SY. Job loss and re-employment of cancer patients in Korean employees: a nationwide retrospective cohort study. J Clin Oncol. 2008;26:1302–9.
Feuerstein M, Todd BL, Moskowitz MC, Bruns GL, Stoler MR, Nassif T, et al. Work in cancer survivors: a model for practice and research. J Cancer Surviv. 2010;4:415–37.
Horsboel TA, De Thurah A, Nielsen B, Nielsen CV. Factors associated with work outcome for survivors from haematological malignancies—a systematic literature review. Eur J Cancer Care (Engl). 2012;21(4):424–35.
Toft Sørensen H, Christensen T, Kjeldahl Schlosser H, Pedersen L. Use of medical databases in clinical epidemiology. Aarhus: Department of Clinical Epidemiology Aarhus University Hospital; 2009.
Pedersen CB. The Danish Civil Registration system. Scand J Public Health. 2011;39:22–5.
Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health. 2011;39:42–5.
Hedegaard Rasmussen. J DREAM Database. The National Labor Market Authority, Ministry of Employment. 2012; version 28.
Jensen C, Jensen OK, Nielsen CV. Sustainability of return to work in sick-listed employees with low-back pain. Two-year follow-up in a randomized clinical trial comparing multidisciplinary and brief intervention. BMC Musculoskelet Disord. 2012;13:156.
Baadsgaard M, Quitzau J. Danish registers on personal income and transfer payments. Scand J Public Health. 2011;39:103–5.
Christensen G. The Building and Housing Register. Scand J Public Health. 2011;39:106–8.
Jensen VM, Rasmussen AW. Danish Education Registers. Scand J Public Health. 2011;39:91–4.
Kildemoes HW, Sorensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health. 2011;39:38–41.
Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999;46:263–8.
Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011;39:30–3.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373–83.
de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity. a critical review of available methods. J Clin Epidemiol. 2003;56:221–9.
Schytz Juul J Teknisk baggrundspapir om indkomstdefinitioner og datagrundlag. 2011.
Mehnert A. Employment and work-related issues in cancer survivors. Crit Rev Oncol Hematol. 2011;77:109–30.
Carlsen K, Dalton SO, Diderichsen F, Johansen C. Danish Cohort Study risk for unemployment of cancer survivors: a Danish cohort study. Eur J Cancer. 2008;44:1866–74.
Syrjala KL, Langer SL, Abrams JR, Storer B, Sanders JE, Flowers MED, et al. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. J Am Med Assoc. 2004;291:2335–43.
Kirchhoff AC, Leisenring W, Syrjala KL. Prospective predictors of return to work in the 5 years after hematopoietic cell transplantation. J Cancer Surviv. 2010;4:33–44.
Marino P, Luis Sagaon T, Laetitia M, Anne-Gaelle l CS. Sex differences in the return-to-work process of cancer survivors 2 years after diagnosis: results from a large French population-based sample. J Clin Oncol. 2013;31:1277–84.
Johnsen AT Kræftpatientens verden: en undersøgelse af, hvilke problemer danske kræftpatienter oplever, Kbh.: Kræftens Bekæmpelse, 2006.
Johnsen AT, Tholstrup D, Petersen MA, Pedersen L, Groenvold M. Health related quality of life in a nationally representative sample of haematological patients. Eur J Haematol. 2009;83:139–48.
Hoybye MT, Dalton SO, Christensen J, Larsen LR, Kuhn KG, Jensen JN, et al. Research in Danish cancer rehabilitation: social characteristics and late effects of cancer among participants in the FOCARE research project. Acta Oncol. 2008;47:47–55.
Acknowledgments
We thank Dr. Peter Hokland for helpful suggestions and former Head Nurse Anette Schouv Kjeldsen as well as Head Nurse Marie Møller for support and encouragement.
This work has been supported by grants from The Danish Cancer Society (grant number R56-A3231), Aarhus University Hospital, The Health Insurance Foundation (grant number 2012B026), Public Health and Quality Improvement, Central Denmark Region, Max and Inger Wørzners Memorial Foundation, and the Andersen-Isted Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Horsboel, T.A., Nielsen, C.V., Nielsen, B. et al. Type of hematological malignancy is crucial for the return to work prognosis: a register-based cohort study. J Cancer Surviv 7, 614–623 (2013). https://doi.org/10.1007/s11764-013-0300-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11764-013-0300-z